Ameritas Investment Partners’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-735
Closed -$875 3367
2025
Q1
$875 Hold
735
﹤0.01% 3108
2024
Q4
$1.51K Hold
735
﹤0.01% 3110
2024
Q3
$1.86K Hold
735
﹤0.01% 3099
2024
Q2
$3.14K Buy
+735
New +$4.73K ﹤0.01% 3071

Other funds holding GUTS

Ameritas Investment Partners's GUTS Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Fractyl Health (GUTS) in Q2 2025, closing a stake of 735 shares — an estimated $875 sold.

Ameritas Investment Partners first reported a position in GUTS in Q2 2024 and held it in 4 quarters. The position peaked at $3.14K in Q2 2024. 62 funds tracked by Wall St. Rank hold GUTS as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Fractyl Health position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 735 Fractyl Health shares in Q2 2025, an estimated $875.
  • Ameritas Investment Partners first reported a position in Fractyl Health in Q2 2024 and held it in 4 quarters.
  • Ameritas Investment Partners's Fractyl Health position peaked at $3.14K in Q2 2024.
  • 62 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.